Health
Who should pay when medical drugs become too expensive to buy?
We depend on private companies to develop new drugs and treatments, but their need to profit has far-reaching consequences
News
Advertisement
We depend on private companies to develop new drugs and treatments, but their need to profit has far-reaching consequences
The US Food and Drug Administration has approved a form of ketamine for use in treatment-resistant depression. While there are unknowns, it is a welcome move, says Celia Morgan